Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

The ostrich mycoplasma Ms01 : the identification, isolation, and modification of the P100 vaccine candidate gene and immunity elicited by poultry mycoplasma vaccines

Thesis (MSc)--Stellenbosch University, 2009.

Saved in:
Bibliographic Details
Main Author: Pretorius, Benita
Other Authors: Bellstedt, D. U.
Format: Thesis
Language:en_ZA
Published: Stellenbosch : Stellenbosch University 2017
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867613798548897792
access_status_str Open Access
author Pretorius, Benita
author2 Bellstedt, D. U.
author_browse Bellstedt, D. U.
Pretorius, Benita
author_facet Bellstedt, D. U.
Pretorius, Benita
author_sort Pretorius, Benita
collection Thesis
dc_rights_str_mv Stellenbosch University
description Thesis (MSc)--Stellenbosch University, 2009.
format Thesis
id oai:scholar.sun.ac.za:10019.1/101533
institution Stellenbosch University (South Africa)
language en_ZA
last_indexed 2026-06-10T12:41:51.674Z
license_str Other — see source repository
provenance_str_mv Harvested via OAI-PMH from SUNScholar — Stellenbosch University Repository
publishDate 2017
publishDateRange 2017
publishDateSort 2017
publisher Stellenbosch : Stellenbosch University
publisherStr Stellenbosch : Stellenbosch University
record_format dspace
source_str SUNScholar — Stellenbosch University Repository
spelling oai:scholar.sun.ac.za:10019.1/101533 The ostrich mycoplasma Ms01 : the identification, isolation, and modification of the P100 vaccine candidate gene and immunity elicited by poultry mycoplasma vaccines Pretorius, Benita Bellstedt, D. U. Botes, Annelise Stellenbosch University. Faculty of Science. Dept. of Biochemistry. South African ostrich industry Ostriches -- Respiratory diseases Poultry mycoplasm vaccine Ostriches immunology Thesis (MSc)--Stellenbosch University, 2009. ENGLISH ABSTRACT: The South African ostrich industry is currently being threatened by respiratory disease in feedlot ostriches with dramatic production losses. Three ostrich-specific mycoplasmas, Ms01, Ms02 and Ms03 were identified to be associated with respiratory disease in ostriches in South Africa. There is currently no registered mycoplasma vaccine available for use in ostriches. In order to prevent mycoplasma infections in South African ostriches, the ostrich industry has launched an investigation into possible strategies for vaccine development. This thesis describes different strategies for the establishment of immunity in ostriches against the ostrich-specific mycoplasmas. Firstly, the effectiveness of existing poultry mycoplasma vaccines to provide protection in ostriches against ostrich mycoplasma infections was tested. To this end, ostriches received primary and secondary vaccinations with poultry mycoplasma vaccines against Mycoplasma synoviae or Mycoplasma gallicepticum, respectively, after which protection against ostrich-specific mycoplasma was evaluated. Even though the specific identity of the ostrich-specific mycoplasmas (Ms01, Ms02, and/or Ms03) responsible for subsequent infection of immunized ostriches was not determined, it was concluded that poultry mycoplasma vaccines do not provide protection against these mycoplasma infections in ostriches. This appears to be the result of low levels of antibody crossreactivity between mycoplasmas, highlighting the necessity for the development of specific vaccines against each of the individual ostrich-specific mycoplasmas. Secondly, the development of a DNA vaccine against Ms01 was investigated. With the aim of developing an Ms01-specific DNA vaccine, the entire Ms01 genome was sequenced using GS20 sequencing technology. Bioinformatic searches were launched for the identification of an appropriate vaccine candidate gene in the Ms01 genome. The P100 gene, showing a high degree of homology with the P100 gene of the human pathogen M. hominis, was subsequently identified. After successful cloning, and modification of ten specific codons within the gene to correct for alternative codon usage, the modified P100 gene of Ms01 is now ready for insertion into a suitable DNA vaccine vector, for subsequent use as a DNA vaccine in ostriches. AFRIKAANSE OPSOMMING: Die Suid-Afrikaanse volstruisbedryf word huidiglik bedreig deur respiratoriese siektes in voerkraal volstruise wat aansienlike produksieverliese tot gevolg het. Drie volstruis-spesifieke mikoplasmas, Ms01, Ms02 en Ms03 is geïdentifiseer wat ‘n rol te speel in respiratoriese siektes in volstruise in Suid-Afrika. Daar is huidiglik geen geregistreerde mikoplasma entstof beskikbaar vir gebruik in volstruise nie. Ten einde mikoplasma infeksies in volstruise te voorkom, het die Suid-Afrikaanse volstruisbedryf ‘n ondersoek geloods na moontlike strategieë vir entstof ontwikkeling. Hierdie tesis handel oor benaderinge om immuniteit in volstuise teen die volstruis-spesifieke mikoplasmas te induseer. Eerstens is die effektiwiteit van bestaande pluimvee mikoplasma entstowwe getoets vir beskerming in volstruise teen volstruis-spesifieke mikoplasmas. Met dit ten doel, is volstruise twee maal met pluimvee entstowwe teen Mycoplasma synoviae of Mycoplasma gallisepticum onderskeidelik geënt, waarna die beskerming teen Ms01 geëvalueer is. Alhoewel die presiese identiteit van die volstruis-spesifieke mikoplasmas (Ms01, Ms02 en/of Ms03) verantwoordelik vir die daaropvolgende infeksies in geïmmuniseerde volstruise nie bepaal is nie, is dit gevind dat die toediening van pluimvee entstowwe nie beskerming gebied het teen hierdie mikoplasma infeksies in volstruise nie. Dit blyk die gevolg te wees van die lae vlakke van antiliggaam kruis-reaktiwiteit tussen mikoplasmas, en beklemtoon dat die ontwikkeling van spesifieke entstowwe vir elk van die volstruis-spesifieke mikoplasmas individueel uitgevoer sal moet word. Tweedens is die ontwikkeling van ‘n DNA entstof teen Ms01 ondersoek. Met die doel om ‘n Ms01- spesifieke DNA entstof te ontwikkel, is die volledige Ms01 genoomvolgorde bepaal deur gebruik te maak van “GS20” volgordebepalingtegnologie. Daarna is bioinformatika soektogte geloods vir die identifisering van ‘n geskikte entstof kandidaat geen in die Ms01 genoom. Die P100 geen, wat hoë homologie toon met die menslike patogeen M. hominis se P100 geen, is geïdentifiseer in Ms01. Na suksesvolle klonering, en die modifisering van tien spesifieke kodons in die geen, is die gemodifiseerde P100 geen van Ms01 nou geskik vir invoeging in ‘n geskikte DNA entstof vektor, vir daaropvolgende gebruik as DNA entstof in volstruise. 2017-05-17T09:35:09Z 2017-05-17T09:35:09Z 2009-03 Thesis http://hdl.handle.net/10019.1/101533 en_ZA Stellenbosch University 117 pages : illustrations application/pdf Stellenbosch : Stellenbosch University
spellingShingle South African ostrich industry
Ostriches -- Respiratory diseases
Poultry mycoplasm vaccine
Ostriches immunology
Pretorius, Benita
The ostrich mycoplasma Ms01 : the identification, isolation, and modification of the P100 vaccine candidate gene and immunity elicited by poultry mycoplasma vaccines
title The ostrich mycoplasma Ms01 : the identification, isolation, and modification of the P100 vaccine candidate gene and immunity elicited by poultry mycoplasma vaccines
title_full The ostrich mycoplasma Ms01 : the identification, isolation, and modification of the P100 vaccine candidate gene and immunity elicited by poultry mycoplasma vaccines
title_fullStr The ostrich mycoplasma Ms01 : the identification, isolation, and modification of the P100 vaccine candidate gene and immunity elicited by poultry mycoplasma vaccines
title_full_unstemmed The ostrich mycoplasma Ms01 : the identification, isolation, and modification of the P100 vaccine candidate gene and immunity elicited by poultry mycoplasma vaccines
title_short The ostrich mycoplasma Ms01 : the identification, isolation, and modification of the P100 vaccine candidate gene and immunity elicited by poultry mycoplasma vaccines
title_sort ostrich mycoplasma ms01 the identification isolation and modification of the p100 vaccine candidate gene and immunity elicited by poultry mycoplasma vaccines
topic South African ostrich industry
Ostriches -- Respiratory diseases
Poultry mycoplasm vaccine
Ostriches immunology
url http://hdl.handle.net/10019.1/101533
work_keys_str_mv AT pretoriusbenita theostrichmycoplasmams01theidentificationisolationandmodificationofthep100vaccinecandidategeneandimmunityelicitedbypoultrymycoplasmavaccines
AT pretoriusbenita ostrichmycoplasmams01theidentificationisolationandmodificationofthep100vaccinecandidategeneandimmunityelicitedbypoultrymycoplasmavaccines